Flu Like Illness
Conditions
Brief summary
This study aimed to evaluate the efficacy and safety of Ayurveda in reducing symptoms of flu like illness during the Covid 19 outbreak.
Interventions
Based on individual constitution (ayurveda based assessment) and symptoms an individual has, ayurveda herbal supplement and self managed practices were advised along with usual care recommendation.
Usual care recommended by National Health Services, self isolation, plenty fluid, rest and Paracetamol. During the Covid 19 outbreak, additional recommendation were followed given by health services.
Sponsors
Study design
Masking description
Ayurveda care provide was blinded
Eligibility
Inclusion criteria
* Patients with fu like symptoms within 48 hours of onset during March2020 * Mild to moderate symptoms who were advised to self isolate at home for 7-14 days * Flu like symptoms present at least one respiratory symptom (e.g. cough, nasal obstruction, sore throat) and at least one constitutional symptom other than fever (e.g. fatigue, headache, myalgias) of less than 48-hour duration * Willing to consent and follow up
Exclusion criteria
* Pregnant/lactating * Participants with chronic pulmonary diseases or critical condition or already developed severe respiratory distress * Clinically malignancies, systemic infection, other medical or psychiatric condition which places the subject at unacceptable risk to participate in the study - Known hypersensitivity to any ayurveda herbal substances * Severe symptoms of respiratory distress patients deemed to require intensive care immediately
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Time to achieve afebrile | Change from baseline to 3rd and 7th-day | Time to bring down a fever (oral temperature \< 37.2 ̊C) |
| Severity of symptom score | Change from baseline to 3rd and 7th day | Symptoms diary card completed twice daily from Day 0 to Day 7 |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Patient reported improvement | Change from baseline to 3rd and 7th-day | Patient reported improvement using 4 scale; 0-none, 1-weak, 2-medium, 3-strong |
Countries
United Kingdom